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Summary It has been suggested that aim of the temporal lobe epilepsy surgery is
twofold: first is to decrease seizure frequency and second is to improve quality of life
without causing intolerable complications. The aim of this prospective, longitudinal
clinical study is to report outcomes with respect to seizure, medication, employment
and quality of life in short- and long-term follow-ups after resective temporal lobe
epilepsy surgery.
Consecutively 63 patients who underwent resective temporal lobe epilepsy surgery
between 1993 and 1994 were enrolled. Outcomes at 6 months, 2 and 12 years were
evaluated and compared with pre-operative status. The mean follow-up of this study
was 12.3  0.6 years.
Results showed that rates of seizure freedom were 82.5, 76.2, and 70.8% at 6
months, 2 and 12 years, respectively. Significant reduction in antiepileptic drug dose
at long-term follow-up was found when compared to baseline. Patients after surgery
had net gain of employment and improved quality of life was seen in all seizure
outcome groups after surgery. Seizure-free patients showed better quality of life than
those who continued to have seizure.
Our results suggest that surgery leads to improvement in both seizure outcome and
quality of life. Even years after the surgery, patients are still working, have reduced
their medication load and have nearly normal life.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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It has been well established that surgery on tem-
poral lobe due to medically refractory epilepsy is an
extremely effective treatment, which controls sei-
zure in almost 60—80% of patients,1,2 thereby lead-
ing to significant improvements in quality of life
(QOL). Recent arouse of interest has shown that. Published by Elsevier Ltd. All rights reserved.
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on the seizure outcome is not sufficient since the
reduction of seizure frequency itself cannot reflect
the improvement of emotional and social well-being
in epileptic patients. Thus, the ultimate goal of
surgery is to improve the QOL.3 Seizure cessation
and/or significant reduction are shown to be corre-
lated with improved QOL and especially seizure-free
(SF) patients are likely to have better QOL.4,5
Over the last two decades, clinical studies have
focused on QOL in patients who had been treated by
medication6,7 or by surgery8—10 and concluded that
QOL and psychosocial outcomes should not be
assessed any earlier than 2 years after surgery11
or one study showed that patients who had surgery
have normal life 3 years after surgery.12 Unfortu-
nately, most of the available data come from the
studies assessing the patients at less than 5 years
after surgery8,9,11—21 and there are only a few pro-
spective studies concerning long-term outcome
beyond 5 years.4,5,10,22—25 In addition, there are
very little data with respect to prospective clinical
studies concerning comparison between pre- and
post-surgery QOL beyond 5 years.5,23 There is only
one recently published prospective clinical study,
which aimed to compare 2 years seizure outcome
and QOL with 10 years follow-up after surgery.25
Patient’s pre-operative data should be included in
prospective studies since the comparison of post-
operative status with the input provides better
understanding on the effectiveness of the treat-
ment that we performed. As far as we know, there
has been no prospective clinical study specifically
concerning the comparison of pre- and post-opera-
tive QOL at long term (i.e., presenting data with
almost 12 years of follow-up) in patients who had
temporal lobe epilepsy surgery due to intractable
epilepsy.
The focus of the present prospective clinical
study is to evaluate baseline and post-surgery QOL
in patients who had been operated due to drug-
resistant temporal lobe epilepsy and to state the
results obtained at 6 months (short term), 2 and 12
years (long term) after surgery.Materials and methods
Patients
The study focused on the operated patients who had
medically resistant temporal lobe epilepsy due to a
variety of causes. In the spirit of a ‘‘before—after’’
study, the concern was to determine whether such
operative success is associated with increase in QOL.
The study was conducted at Montreal NeurologicalInstitute (MNI), a tertiary care center with a long-
established multidisciplinary team of epilepsy spe-
cialists. Patients come to MNH from within and out-
sideCanada. Thepatients referred toMNI for possible
surgery have severe and complex seizure disorders,
medically intractable for many years. The extensive
evaluation process included discontinuation of anti-
epileptic drugs (AEDs) for electroencephalography
studies, depth electrode monitoring of seizures in
selected patients, neuropsychologic evaluation and,
if indicated, amytal speech and memory testing and
radiological investigation. All patients included in
this study admitted to the epilepsy service at the
MNI between 14 December 1993 and 6 October 1994.
Sixty-three patients were included in this study. Our
inclusion criteria were (a) confirmed diagnosis of
epilepsy, with medically intractable seizures and
no previous surgical treatment, (b) age at least 17
years, and (c) no history of chronic psychiatric illness
or evidence of mental retardation. All data were
available before surgery, at 6 months and 2 years
follow-ups for all 63 patients, however, at 12 years
after surgery, since 15 patients were lost to follow-
up, 48 (76%) patients were assessed. Thus, in this
study, 63 patients’ data at 6 months and 2 years and
48 patients’ data at 12 years after surgery were
evaluated and compared to both each other and
baseline. Baseline clinical and socio-demographic
profiles are summarized in Table 1.
Surgery
Surgical procedures in all patients were performed
by the same surgeon (A.O.). The surgical techniques
of selective amygdalohippocampectomy, cortico-
amygdalohippocampectomy and lesionectomy on
temporal lobe have been described in detail else-
where.1,2 Table 1 also demonstrates the types of
surgical techniques performed in the patients.
Histopathological study
Hippocampal and lesional tissues sufficient for his-
topathological diagnosis were available in all
patients. The resected specimens were histopatho-
logically examined with previously described tech-
niques.26 Majority of the patients were diagnosed as
mesial temporal lobe epilepsy either gliosis or
sclerosis (Table 1).
Post-operative evaluation
Patients were discharged on therapeutic dosages of
at least one first-line AED. The first follow-up was
performed at 6 weeks following the surgery and 6
months in the first year and yearly thereafter, either
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Table 1 Demographic characteristics of patients eval-
uated in this study
Factors Value
Basic characteristics
Mean (standard deviation)
age (years)
34.4  11.3
Gender (female/male) 32/31
Handedness (right/left/
ambidextrous)
51/11/1
Seizure characteristics
Mean (standard deviation)
age at seizure onset (years)
7.1  9.3
Mean (standard deviation)
duration of seizure (years)
27  12.7
Frequency of seizure
Day 8.3  16.4
Week 0.1  0.7
Month 14.3  32
Year 0.03  0.2
History
Febrile seizure (yes/no) 20/43
Perinatal difficulties (yes/no) 6/57
Developmental delay (yes/no) 3/60
Trauma (yes/no) 12/51
Meningitis/encephalitis (yes/no) 13/50
Imaging (magnetic resonance imaging)
Hippocampal atrophy 52
Tumors 7
Vascular lesions 3
Dysplasia 1
SEEG (yes/no) 6/57
Surgery
Mean (standard deviation)
age at surgery (years)
33.8  11.2
Side of surgery (right/left) 29/34
Types of surgery
SAH 33
CAH 20
SAH + lesionectomy 4
CAH + lesionectomy 6
Complications (yes/no) 5/58
Histopathological diagnosis
Gliosis 38
Sclerosis 14
Tumors 7
Vascular lesion 3
Cortical dysplasia 1
CAH: cortico-amygdalohippocampectomy; SAH: selective
amygdalohippocampectomy; SEEG: stereotactic-electroence-
phalography.through outpatient visits or telephone interviews.
Outcome was assessed independently by the neuro-
logical and neurosurgical teams. All patients had
MRI, scalp EEG and neuropsychologic evaluations
during the follow-up periods. In this study, seizure
outcome and QOLwere evaluated at 6months, 2 and
12 years post-operatively.
Seizure outcome
Outcome at 6-month and 2-year follow-ups in rela-
tion to seizure control was based on Engel’s classi-
fication, using all 12 subclasses (modified Engel
classification),27 thus different from some other
studies ‘‘aura only’’ was classified as ‘‘not sei-
zure-free’’ (NSF) since it has been demonstrated
that even ‘‘only aura’’ after surgery has negative
impact on QOL. For categorical comparisons, this
classification was divided into favorable [(Engel
classes I and II)] and unfavorable [(Engel classes III
and IV)] seizure outcomes. ‘‘Seizure-free’’ group in
this study included only the patients who had been
seizure-free since surgery (Engel Ia).
Quality of life assessment
In this study, quality of life inventory in epilepsy-10
(QOLIE-10) was used. The QOLIE-10 is a self-admi-
nistered questionnaire designed for completion by
patients alone andwas derived from the QOLIE-31.28
It consists of 10 questions designed to assess the
patients’ subjective rating of their memory, level of
physical and mental well-being, energy, depression,
worries about seizures and work, social limitations,
and overall quality of life. Each item in the ques-
tionnaire is ranked on a scale of 1—5, the lower the
score on the QOLIE-10, the better the QOL. The
QOLIE-10 is specific for epilepsy and reliability and
validity have recently been proved and found that it
is rather reliable as compared with its longer ver-
sion, the QOLIE-31.29,30Statistical analysis
The data were analyzed using SPSS computer soft-
ware (SPSS Version 11.0.1; SPSS Inc., Chicago, IL).
Tests of significance used were the ‘‘Mann—Whitney
U-test’’ with exact probabilities corrected for ties;
‘‘Kendall’s b’’ correlation coefficient corrected for
ties, and for categorical variables x2 was used. For
the purpose of analysis, the datawere split into those
who were seizure-free and those who continued to
have seizures or not seizure-free. We also used non-
parametric analysis to compare differences between
scores obtained at 6 months, 2 and 12 years.
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QOLIE-10 questionnaire was completed by 63
patients before 6 months and 2 years after the
surgery. In 12 years after surgery, 48 (76%) patients
completed the questionnaire by phone contact.
Fifteen patients were lost to long-term follow-up:
13 patients were not contacted probably due to
address or telephone number changes and 2 patients
died (mothers told on the phone) due to non-epi-
lepsy-related causes. The subject pool comprised 32
females and 31 males, with a mean age of
34.4  11.3 years (Table 1). The mean follow-up
was 12.3  0.6 years.
Seizure outcome
At 6 months, 2 and 12 years follow-ups, patients
were included in favorable seizure outcome (FO) as
follows: 61 (96.8%), 61 (96.8%), and 46 patients
(95.8%), respectively. There was no statistically
significant difference regarding FO between 2 and
12 years (x2, p = 0.08). A total of 52 (82.5%), 48
(76.2%), and 34 (70.8%) patients were completely SF
(Engel Ia) without aura after tough questioning
concerning of presence or absence of aura at 6
months, 2 and 12 years after surgery, respectively
and no patients were left with a worse seizure
frequency or severity following surgery (no Engel
IVb). The difference between 2 and 12 years afterTable 2 Seizure and antiepileptic drug use outcomes
Factor Baseline (N = 63) 6 months
SF (52) NSF
Seizure outcome
Ia — 52 (82.5%) —
Ib — — 2 (3.
Ic — — —
Id — — 3 (4.
IIa — — 2 (3.
IIb — — 1 (1.
IId — — 1 (1.
IIIa — — 2 (3.
Overall outcome
FO — 61 (96.8%)
UFO — 2 (3.1%)
AED outcome
Mean number 2.3  1.0 1.63  0.7
Off medication — —
Monotheraphy 11 (17.5%) 31 (49.2%)
Two AEDs 27 (42.9%) 24 (38.1%)
Three AEDs 17 (27%) 8 (12.7%)
>3 AEDs 8 (12.6%) —
AED: antiepileptic drug; FO: favorable outcome (Engel I + II); NSF:
(Engel III + IV).surgery with respect to seizure freedom was statis-
tically significant (x2, p = 0.04). The rate of seizure
freedom showed a trend to decrease from 52 (82.5%)
to 34 (70.8%) during follow-ups (Table 2).
Medication outcome
At the MNI, reduction toward a cessation of AEDs is
tailored to each individual; all patients’ progress
through an extended period of AED tapering before
medication ceases. Table 2 demonstrates the AED
use following surgery. As can be seen in Table 2, the
mean number of AEDs prescribed decreased with
time and comparison between baseline and follow-
ups regarding dose reduction disclosed statisti-
cally significant difference (Mann—Whitney U-test;
p = 0.0001) regardless of seizure outcome. Carba-
mazepine was the most prescribed AED followed by
Phenytoin before and after surgery. AEDs dose sig-
nificantly reduced at 2 years (Mann—Whitney U-test;
p = 0.0001) and 12 years (Mann—Whitney U-test;
p = 0.0001) compared to 6 months. However,
although mean AEDs dose at 12 years was found
to be lower than at 2 years after surgery, the
difference did not reach significant level (Mann—
Whitney U-test; p = 0.06). Of the 63, 20 (31.7%)
patients no longer took AEDs at 2 years after surgery
and all were SF. Of those 43 patients who continued
to take AEDs, 28 (65.1%) were SF and 3 (6.9%) had
only aura (Ib). At 12 years follow-up, 23 (47.9%) of 482 years 12 years
(11) SF (48) NSF (15) SF (34) NSF (14)
48 (76.2%) — 34 (70.8%) —
2%) — 3 (4.8%) — 4 (8.3%)
— — — 1 (2.1%)
8%) — 4 (6.3%) — 1 (2.1%)
2%) — 5 (7.9%) — 4 (8.3%)
6%) — — — —
6%) — 1 (1.6%) — 2 (4.2%)
2%) — 2 (3.2%) — 2 (4.2%)
61 (96.8%) 46 (95.8%)
2 (3.1%) 2 (4.2%)
1.0  0.9 0.6  0.7
20 (31.7%) 23 (47.9%)
27 (42.9%) 17 (35.4%)
11 (17.5%) 8 (16.7%)
5 (7.9%) —
— —
not seizure-free; SF: seizure-free; UFO: unfavorable outcome
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patients although did not have seizure refused to
stop medication at long term. A better seizure out-
come was associated with a higher rate of disconti-
nuation or reduction of AEDs at short-term (6
months and 2 years) but not at long-term (12 years)
follow-up. The comparison between SF patients and
those with rare or frequent persistent seizures with
respect to the AED regimen (discontinuation or
reduction vs. no change or increase) was statisti-
cally significant at 6 months (Mann—Whitney U-test;
p = 0.001) and at 2 years (Mann—Whitney U-test;
p = 0.001) but not at 12 years (Mann—Whitney U-
test; p = 0.17).
Employment outcome
Of the 63 patients, 16 (25.3%) were students at the
time of surgery (Table 3). Prior to surgery, 6 (9.5%)
could not go to school due to epilepsy, 2 (3.2%) was
going to school part-time and 8 (12.7%) were at the
school full-time. The students who could not go to
school before surgery were able to go to school 6
months after surgery. One and three students who
were SF graduated from the university at 6 months
and 2 years following surgery, respectively and
begun to work full-time. By 12 years after surgery,
all graduated from their schools. Regardless of sei-
zure outcome, post-operative short-term (6 months
and 2 years) and long-term (12 years) school status
was significantly improved compared to baseline
(x2; p > 0.05). Shifts from part-time to full-time
going to school were statistically significant regard-
ing follow-ups (x2; p > 0.05) and there was a sig-
nificant difference between SF and NSF patients
with respect to shift from part-time to full-time
school (x2; p > 0.05).Table 3 Employment outcome of the patients included in
Factor Baseline (63) 6 month
School
Cannot goa 6 (9.5%) —
Part-time 2 (3.2%) 3 (4.8
Full-time 8 (12.7%) 12 (19%
Job
Lost jobb 22 (34.9%) 7 (11.
Part-time 3 (4.8%) 10 (15.
Full-time 15 (23.8%) 20 (31.
Housewife 8 (12.7%) 8 (12.
Cannot findc — 3 (4.7
Retired — —
Lost jobd — —
a Students who could not go to school due to epilepsy.
b Patients who lost their job due to epilepsy.
c Patients who cannot find job although they have no seizure.
d Patients who are seizure-free but lost their job due to some otBefore surgery, 22 (34.9%) lost their job due to
seizure and 18 (28.5%) patients were working part-
time or full-time. Employment was significantly
improved compared to baseline regardless of sei-
zure outcome (x2; p > 0.05). In the same context,
the shift from part-time to full-time working
increased during follow-up and there was a statis-
tically significant difference between follow-ups
when compared to each other (x2; p > 0.05). SF
patients had higher employment rate than NSF
patients at short- and long-term (12 years) follow-
ups and the difference was statistically significant in
terms of employment rate (x2; p > 0.05). The SF
patients in general continued to work over time and
shifted from part-time to full-time. At 12 years
follow-up, although they had no seizure, 4 (8.3%)
patients could not find job and 1 with SF lost job due
to other reasons (Table 3).Quality of life outcome
Overall QOL: regardless of seizure
outcome
Table 4 demonstrates mean (standard deviations)
scores of subscales in QOLIE-10 questionnaire before
6 months, 2 and 12 years after surgery. There was a
trend to improve QOL after surgery, even at very
early follow-up (6 months). The highest score
(worst) was found in ‘‘driving problems’’ subscale
of QOLIE-10 followed by ‘‘overall QOL’’ subscale,
suggesting that seizure most commonly affects
social functioning domain of patient’s life before
surgery. Regardless of seizure outcome, comparing
baseline scores with the scores obtained at 6 months
(Mann—Whitney U-test; p = 0.00001), 2 yearsthis study
s (63) 2 years (63) 12 years (48)
— —
%) 2 (3.2%) Graduated
) 11 (17.5%) Graduated
1%) 2 (3.2%) —
9%) 7 (11.1%) 2 (4.2%)
7%) 31 (49.2%) 30 (62.5%)
7%) 8 (12.7%) 6 (12.5%)
%) 3 (4.7%) 4 (8.3%)
— 5 (10.4%)
— 1 (2.1%)
her reasons.
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Table 4 Mean (S.D.) scores of subscales of QOLIE-10a before and after surgery
Subscales of QOLIE-10 Baseline 6 months 2 years 12 years
Number of patients 68 68 68 48
Seizure worry
Fear for seizure 3.2  1.4 1.7  1.2 1.7  1.2 1.3  0.7
Well-being
Depressive feelings 3.0  1.2 2.0  0.9 1.5  0.8 1.6  0.9
Energy
Limited energy 3.0  1.2 1.9  0.9 1.5  0.7 1.7  0.8
Cognitive functioning
Having memory problems 3.3  1.4 2.2  1.1 2.0  1.1 1.6  0.9
Medication effects
Physical side-effects of AEDs 3.5  1.3 2.3  1.3 1.8  1.1 1.4  0.8
Mental side-effects of AEDs 2.8  1.2 2.2  1.1 1.6  0.9 1.3  0.7
Social functioning
Problems with car driving 4.5  1.2 2.3  1.7 1.5  1.3 1.9  1.5
Limitation in work 3.6  1.4 2.3  1.4 1.8  1.2 1.5  1.0
Limitation in social life 3.3  1.3 2.1  1.4 1.6  1.1 1.4  0.9
Quality of life
Overall quality of life 3.7  0.9 1.6  0.8 1.4  0.5 1.6  0.7
AED: antiepileptic drug; S.D.: standard deviation; QOLIE: quality of life inventory in epilepsy.
a The lower the score, the better the QOL.
Figure 1 Graphic representations of subscales of quality
of life inventory epilepsy-10 (QOLIE-10) before and after
surgery. Significant improvements in all QOL subscales
were found in patients very early after 6 months and long
term (2 and 12 years) following surgery ( p = 0.00001)
compared to baseline. Furthermore, seizure-free (Ia)
patients at 6 months ( p = 0.001), 2 and 12 years
( p = 0.002 and 0.016, respectively) after surgery showed
significantly improved overall QOL score compared to
patients who continued to have seizure. (For interpreta-
tion of the references to color in this artwork, the reader
is referred to the web version of the article.)(Mann—Whitney U-test; p = 0.00001), and 12 years
(Mann—Whitney U-test; p = 0.00001) demonstrated
significant differences in all items of the question-
naire (Fig. 1).
When we compare QOL outcomes obtained at 6
months and 2-year follow-up, a global decrease
(better) QOL values at 2 years post-surgery was
documented in almost all 10 items (Table 4). How-
ever, there were no statistically significant differ-
ences regarding to social functioning (limitations in
work and social life), memory problems, seizure
worry (fear for having seizure again), and overall
QOL (Mann—Whitney U-test; p > 0.05). When we
compared early (6months) follow-up with long-term
(12 years) follow-up, all but ‘‘overall QOL’’ subscale
showed lower (better) scores at 12 years; however,
patients still felt limited energy, have problems with
car driving, have fear for having seizures (Mann—
Whitney U-test; p = 0.001). Interestingly, ‘‘overall
QOL’’ subscale score at 12 years was not better than
at 6 months and the difference was not significant
(Mann—Whitney U-test; p = 0.001). Comparing 2 and
12 years disclosed interesting findings. QOLIE-10
subscales were significantly better at 12 years in
only 2 subscales: patients noted that at 12 years
they had less memory problems (Mann—Whitney U-
test; p = 0.04), and perceived less mental side-
effects of AEDs (Mann—Whitney U-test; p = 0.02).
The most common problem noted by the patients at
12 years was the problems in driving and the dif-
Epilepsy surgery and quality of life 345ference was statistically significant compared to 2
years regarding ‘‘problems with car driving’’ sub-
scale (Mann—Whitney U-test; p = 0.04). Other unex-
pected findings were that patients regardless of
seizure outcome noted that they were depressed,
felt less energetic and their ‘‘overall QOL’’ was not
better 12 years than it was at 2 years after surgery
although the differences did not reach significant
level.
Seizure outcome and quality of life:
seizure-free versus not seizure-free
At 6-month follow-up, SF patients showed lower
score (better) than NSF patients in all 10 items of
QOLIE-10 questionnaire. Comparing the subscales
showed significant differences in 8 subscales
(Mann—Whitney U-test; p > 0.05); however ‘‘lim-
ited energy’’ (Mann—Whitney U-test; p = 0.08) and
‘‘physical side-effects’’ scores (Mann—Whitney U-
test; p = 0.09) did not show significant difference.
The most common problem was found in car driving
in patients who had seizure 6 months after surgery.
At 2-year follow-up, in general speaking, all sub-
scales showed lower (better) mean score in SF
patients than those who continued to have seizure.
In 9 subscales of the questionnaire, SF patients
noted significantly better scores than those of NSF
patients (Mann—Whitney U-test; p > 0.05) but they
still felt limited energy (Mann—Whitney U-test;
p = 0.012). Difficulties in memory and car driving
were the two common problems that noted were by
the patients at 2 years follow-up.
At long-term (12 years) follow-up, again SF
patients showed better QOL than those who contin-
ued to have seizure in all aspects of QOLIE-10 ques-
tionnaire. However, 3 subscales including ‘‘memory
problems’’ (Mann—Whitney U-test; p = 0.26), ‘‘lim-
itation in social life’’ (Mann—Whitney U-test;
p = 0.13), and ‘‘physical side-effects’’ of AEDs
(Mann—Whitney U-test; p = 0.1) did not reach signif-
icant level between SF and NSF patients 12 years
after surgery. The most common problem noted by
the patients with seizure at 12 years was in car
driving.
Medication and quality of life
A better QOL was associated with a higher rate of
discontinuation or reduction of AEDs at 2 and 12
years after surgery. Patients who were off medica-
tion had lower (better) mean scores in all 10 items of
QOLIE-10 compared to those who continued to use
AEDs at both 2 and 12 years after surgery. At 2 years,
patients who were off medication noted that they
had significantly improved memory (Mann—WhitneyU-test; p = 0.04), had less physical (Mann—Whitney
U-test; p = 0.003) and mental (Mann—Whitney U-
test; p = 0.004) side-effects and improved overall
QOL (Mann—Whitney U-test; p = 0.01) compared to
patients who were still on AEDs. At 12 years,
patients who were off AEDs noted that they had
more energy (Mann—Whitney U-test; p = 0.008), less
driving problems (Mann—Whitney U-test; p = 0.02),
less physical side-effects of AEDs (Mann—Whitney U-
test; p = 0.006), and had significantly improved
overall QOL (Mann—Whitney U-test; p = 0.04) com-
pared to those who were still on AED medication.Discussion
In this prospective clinical study, we have reported
short- and long-term outcomes with respect to sei-
zure, medication, employment, and QOL in conse-
cutive patients who had temporal lobe surgery due
to medically resistant epilepsy between 1993 and
1994, a mean follow-up of 12.3 years. Depending on
present data, we could suggest that surgery has (1)
improved seizure outcome; (2) decreased medica-
tion use; (3) caused net employment gain; and (4)
improved overall QOL in patients with temporal lobe
epilepsy.
Previous outcome studies regarding QOL after
surgical treatment are prospective with short-term
follow-up (1—2 years),9,13,16 or retrospective with
again short-term follow-ups.8,14,15 Some studies
compared surgically treated groups with nonsurgi-
cally treated groups11,12,17,20,22 and some reported
their results without comparing baseline data.4,10,11
There have been only two clinical studies that
reported outcomes regarding QOL at long-term fol-
low-up. The first one was a clinical study comparing
QOL between SF and NSF patients almost 10 years
after surgery.4 However, this study lacks baseline
data and was retrospective in nature.4 The second
one reported outcomes with respect to seizure, AED
use, and psychosocial outcomes almost 10 years
after surgery.25 This study compared long-term
results with the 2-year follow-up, without compar-
ing baseline.25 Regardless of the limitations, long-
term studies concerning QOL or other measures are
more important than those of short-term studies
and prospective rather than retrospective nature
provides better understanding related to the course
of the disease after surgery and to the effect of
treatment that is performed. It has been clearly
demonstrated that improvement in QOL after sur-
gery requires at least 2 years being manifested11;
thereby, psychosocial outcomes should not be stu-
died any time shorter than 2 years. Present study
will be the first prospective study presenting long-
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outcome, AED use, employment and QOL in pre- and
post-operative periods.
The rate of seizure freedom in our series at
different intervals after surgery is in accordance
with other long-term studies.4,25,31 In our study,
we think that the actual rate of seizure freedom
at short- and long-term follow-ups were reported
since all subscales of Engel’s classification was used
and after meticulous questioning ‘‘aura only’’ was
not included in NSF patients since it has been shown
that even ‘‘aura only’’ has also negative effects on
quality of life.8 Seizure freedom rate decreased
from 82.5 to 70.8% during time after surgery which
was in accordance with a recently published meta-
analysis study reported by Tellez-Zenteno et al.31
who found an association between duration of fol-
low-up and seizure outcome (i.e., the longer the
follow-up, the poorer the seizure outcome). How-
ever, our results are in contrast with the long-term
results reported by Asztely et al.25 who reported
sustained rate of seizure outcome from time after
surgery. The discrepancy between our results and
data reported by Asztely et al.25 might be largely
due to the patients who were included in this study
had temporal and extratemporal lobe epilepsy.25 In
our series, patients had epilepsy coming from only
temporal lobe and the majority were due to mesial
temporal lobe. It has been well-known that course,
surgical treatment and outcome in extratemporal
lobe epilepsy are extremely different from temporal
lobe epilepsy.32 Nevertheless, our results lend sup-
port to the notion that temporal lobe epilepsy
surgery leads to seizure freedom in a considerable
number of patients, even at long-term follow-up.
Considering AEDs use, different results have been
published. In some studies, it has been found that
there is an inverse association between duration of
follow-up and proportion of patients discontinuing
AEDs31; however, this notion is not supported by
others10,25 and our results. AEDs use in our study
showed an associated with better seizure outcome
(the better the seizure outcome, the lesser the AEDs
use). In present study, the proportion of SF patients
who had stopped AEDmedication at 2 years (19 of 48
patients; 39.5%) and at 12 years (18 of 34 patients;
52.9%) was similar to that reported in other stu-
dies.10,25,33 Actually, we do not have an explanation
for the discrepancy between our results and some
meta-analytic studies31 but we can speculate that
the difference may be due to the patients (15
patients in our study) who were lost to 12 years
follow-up and we think that it is difficult to interpret
AEDs use prospectively since decision on the dis-
continuation of AED is influenced by many factors
(e.g., doctor, patient or family preferences). Takentogether, our results suggest that temporal lobe
epilepsy surgery has positive impact on AEDs use
at long-term follow-up and seizure outcome is asso-
ciated with reduction or discontinuation of AED use.
Several studies showed that unemployment is a
major problem in patients with epilepsy34 and sur-
gery improved employment gain.21,25 Gainful
employment is a good predictor of overall well-
being and patient satisfaction post-operatively
and, therefore, represents an important outcome
for patients. However in some studies it has been
reported that surgery does not make a significant
contribution to the actual employment except for
patients who already lost their job or already in
part-time employment.14,35 On the other hand, a
few studies have shown that patients who become
SF are more likely to maintain their job and improve
economic situation than those who had sei-
zure.14,21,25 This notion is supported by our results
that SF patients were more likely to have been
employed before surgery than in the other outcome
groups, suggesting that they may be less disabled by
their seizures and, therefore, would be more likely
to have better post-surgery outcome and some
patient had progressed from part-time to full-time
employment. Significantly more previously unem-
ployed people or people who lost their job due to
epilepsy had found or regained their jobs in SF
group, consistent with the findings from recent
long-term studies.21,25 In contrast, only 42.5% of
NSF patients were employed (part- and full-time)
compared to 73.6% of SF patients after excluding
retired patients and patients who could not find or
lost their jobs due to other reasons 12 years after
surgery. In fact we felt during survey of present
study that some patients who were seizure-free
and off medication at long term do not want to
get job and this may influence the employment rate.
Nevertheless, seizure outcome affects employment
and SF patients are more likely to gain employment
or at least maintain their economic conditions com-
pared to NSF patients. Temporal lobe epilepsy sur-
gery regardless of seizure outcome has led to net
gain in employment at both short- and long-term
follow-ups.
During the last two decades, epilepsy centers all
over the world have begun to report different
aspects of life evaluated by different types of
methods designed specifically for epileptic patients
following surgical or medical treatments. However,
only in recent years, prospective clinical studies
with five or more than five follow-ups appeared in
the literature.5,23,24 Up to date there have been
only two longitudinal clinical, one retrospective
(10.3 years follow-up)4 and one prospective (12.4
years follow-up),25 studies evaluating QOL in
Epilepsy surgery and quality of life 347patients underwent epilepsy surgery. Different
types of QOL questionnaire used in the clinical
studies disclosed some differences in the results
but the common notion is that seizure freedom is
the key to success.
In the present study, we used health-related
QOLIE-10 questionnaire which was derived from
formerly developed questionnaire for epilepsy,
QOLIE-31.28 The validity and reliability of QOLIE-
10 compared to its former form have been well
demonstrated.29,30 Our analysis shows that regard-
less of seizure outcome, QOL improves significantly
immediately after epilepsy surgery compared to
baseline and these improvements sustain at long-
term follow-ups as reported previously.5,36 Even
patients who had seizures after surgery showed
better QOL than baseline. SF patients have always
noted better scores than those who continued to
have seizures at short term (6 months) and long
term (2 and 12 years) following surgery. However,
we have found that SF patients had still some
problems such as they were less energetic, still
had physical side-effects of AEDs even at 12 years
after surgery. For individual basis, we have noted
that if seizure persists, declines in QOL begin after
earliest testing (6 months) and continue to decline
to pre-surgical level. The explanation why patients
feel that their QOL improved at early assessment is
that it is possible that there is a feeling of relief
after surgery, which was translated into improved
QOL as suggested by others.5 Comparing 6 months,
2 and 12 years to each other regardless of seizure
outcome revealed interesting findings. When
patients were asked ‘‘how has the quality of your
life been during the past 4 weeks? That is, how have
things been going for you?’’ The patients were
asked to circle one number (ranging number 1: very
well to 5: very bad). Comparison of short- to long-
term data showed insignificant difference, suggest-
ing that even after 12 years patients are not still
happy. In our study, some patients who had no
seizure and were not on medication complained
of their families who restricted them to join their
friends, to go somewhere alone, etc. These findings
suggest that evaluating the aspects of life is not
easy and is dependent on some other factors.
Another interesting finding that we found was that
at least 7 subscales of QOLIE-10 questionnaire
did not show statistically significant difference
between 2 and 12 years after surgery regardless
of seizure outcome. Our findings are consistent
with McLachlan et al.11 who specifically noted that
improvements in QOL require at least 2 years being
manifested and Mikati et al.12 who showed that
normalization of QOL after epilepsy surgery
requires 3 years since they showed QOL of thesurgery patients was similar to that of healthy
controls 3 years after surgery. When we consider
our results obtained at 2 and 12 years, it seems
logical that QOL would not continue to improve
with continued seizure-free status beyond a certain
level since as time goes on SF patients perceive
themselves as ‘‘cured’’ and improvements reach
the levels of general population. We think that
reaching this ‘‘ceiling effect’’ at long-term or
post-operative adjustment problems can arise as
patients learn to live without chronic epilepsy; a
concept described as the ‘‘burden of normality’’ at
long term can explain why we did not find signifi-
cant difference in majority aspects of question-
naire between 2 and 12 years. It is also notable
that even best seizure outcome patients still have
social limitations at 12 years led us to think the
concept of ‘‘burden of normality.’’ All together,
although different results are reported so far, our
analysis supports the common notion that surgery
causes improvements in QOL in patients with tem-
poral lobe epilepsy and SF patients are more likely
to have better life than those who continues to
have seizure after surgery. QOL in patients with
reduced numbers of seizures seems improved but to
a lesser degree and have better QOL than they were
before surgery.Limitations
The authors acknowledge the limitations of this
investigation. First, our sample size was modest
and the results were not compared with those of a
control (healthy population). Second, as in many
prospective follow-up studies, there were patients
lost to follow-up over time; 15 (23.8%) patients in our
study at 12 years after surgery and thismay represent
a bias in participating subjects. Globally, the char-
acteristics of the patients in whom we did not reach
were similar to thoseof thepatients inwhomwewere
able to reach. Despite limitations, the value of our
study lies in its prospective nature and long-term
follow-up period after epilepsy surgery. Further-
more, a comparison of short- and long-term result
with baseline is another value of our study since our
study is the first prospective one comparing the data
obtained at 12 years and baseline.Conclusion
Surgery leads to improvement in both seizure out-
come and quality of life. Even years after the sur-
gery patients are still working, have reduced their
medication load and have nearly normal life and it is
348 T. Tanriverdi et al.clear that post-surgical seizure status is an essential
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